CAS 774596-24-6
:2,3,5,6-tetradeuteriopyridine-4-carbohydrazide
Description:
2,3,5,6-Tetradeuteriopyridine-4-carbohydrazide is a chemical compound characterized by its unique structure, which includes a pyridine ring substituted with a carbohydrazide functional group. The presence of deuterium atoms, indicated by the prefix "tetradeutero," suggests that this compound is a labeled version of pyridine-4-carbohydrazide, where four hydrogen atoms have been replaced with deuterium isotopes. This substitution can significantly influence the compound's physical and chemical properties, such as its stability, reactivity, and isotopic behavior in various reactions. The compound is likely to be used in research applications, particularly in studies involving isotopic labeling, which can aid in tracking reaction pathways or understanding mechanisms in organic chemistry. Additionally, the hydrazide functional group may impart biological activity, making it of interest in medicinal chemistry. Overall, 2,3,5,6-tetradeuteriopyridine-4-carbohydrazide is a specialized compound with applications in both synthetic and analytical chemistry.
Formula:C6H3D4N3O
InChI:InChI=1/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)/i1D,2D,3D,4D
SMILES:c1(c(nc(c(c1C(=O)NN)[2H])[2H])[2H])[2H]
Synonyms:- (< sup> 2< /sup> H< sub> 4< /sub> )Pyridine-4-carbohydrazide
- 4-Pyridine-D< Sub> 4< /Sub> -Carboxylic Acid, Hydrazide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Isoniazid-d4 (Isonicotinoyl-d4 Hydrazide)
CAS:Formula:C6H3D4N3OColor and Shape:White To Off-White SolidMolecular weight:141.17Isoniazid-d4
CAS:Isoniazid-d4 is a deuterium isotope marker for Isoniazid.Isoniazid is a prodrug that must be activated by the bacterial peroxidase KatG, and is bactericidal.Formula:C6H3D4N3OColor and Shape:SolidMolecular weight:141.16Isoniazid-d4
CAS:Controlled Product<p>Applications Labelled Isoniazid. Antibiotic for treatment of Mycobacterium tuberculosis, inhibits mycolic acid biosynthesis. Metabolized by hepatic N-acetyltransferase (NAT) and cytochrome P450 2E1 (CYP2E1) to form hepatotoxins. Selectively induces expression of CYP2E1. Reversibly inhibits CYP2C19 and CYP3A4 activities, and mechanistically inactivates CYP1A2, CYP2A6, CYP2C19 and CYP3A4 at clinically relevant concentrations. Antibacterial (tuberculostatic).<br>References Brewer, G.A., et al.: Anal. Profiles Drug Subs., 6, 183 (1977), Weber, W.W., et al.: Clin. Pharmacokinet., 4, 401 (1979)<br></p>Formula:C62H4H3N3OColor and Shape:White To Light BeigeMolecular weight:141.16




